Humana: A Beaten-Down Health Care Stock to Re-Emerge as Inflation Fades
Humana's stock has faced a sharp sell-off, but fundamentals remain strong, with a potential 40% to 50% upside within 24 months as headwinds fade.
Humana's Falling Share Price Gives Investors An Opportunity
Humana has slid 10% due to exiting 13 markets, raising investor concerns, but remains attractive due to strong profitability and management alignment with investor interests. Despite trailing the S&P 500, Humana's core profitability is impressive, with NOPAT rising even as GAAP net income declined. Executive compensation tied to ROIC ensures management is incentivized to create value, making Humana a good long-term investment.
Humana (HUM), Evergreen Nephrology Partner to Improve Health Outcomes
HUM collaborates with Evergreen Nephrology to introduce a specialized care program for chronic kidney disease patients.
Why Is Humana (HUM) Down 2.1% Since Last Earnings Report?
Humana (HUM) reported earnings 30 days ago. What's next for the stock?
$50 To $70 In Less Than A Year: Is Johnson Controls Stock Headed To $80 Next?
Johnson Controls stock (NYSE: HUM) currently trades around $70 per share, compared to its peak levels of over $80 seen in January 2022. While the company's stock has shed more than 10% of its value, Carrier stock (NYSE: CARR) has risen around 40% over the same period.
Can Humana Stock Return To $500 From Its Current Level Of $350?
Humana (NYSE: HUM) currently trades around $355 per share, nearly 30% below its peak level of $495 seen in September 2022. In comparison, UnitedHealth stock (NYSE: UNH) saw its stock rise 13% over the same period.
The Schall Law Firm Urges Shareholders Who Sustained Losses With Humana Inc To Initiate Dialogue
LOS ANGELES, CA / ACCESSWIRE / August 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Humana Inc. ("Humana" or "the Company") (NYSE:HUM) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between July 27, 2022 and January 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before August 2, 2024.
HUM LAWSUIT ALERT: Levi & Korsinsky Notifies Humana Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, NY / ACCESSWIRE / August 2, 2024 / If you suffered a loss on your Humana Inc. (NYSE:HUM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
FINAL HUM DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Humana Inc. Investors to Join the Class Action Lawsuit!
NEW YORK, NY / ACCESSWIRE / August 2, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Humana Inc. ("Humana" or "the Company") (NYSE:HUM) and certain of its officers. Class Definition: This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Humana securities between July 27, 2022 and January 24, 2024, inclusive (the "Class Period").
Investors in Humana Inc. Should Contact Levi & Korsinsky Before August 2, 2024 to Discuss Your Rights - HUM
NEW YORK, NY / ACCESSWIRE / August 2, 2024 / If you suffered a loss on your Humana Inc. (NYSE:HUM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
Shareholders that Lost Money on Humana Inc. (HUM) Should Contact Levi & Korsinsky About Pending Class Action - HUM
NEW YORK, NY / ACCESSWIRE / August 2, 2024 / If you suffered a loss on your Humana Inc. (NYSE:HUM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
Levi & Korsinsky Reminds Humana Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 2, 2024 – HUM
NEW YORK, NY / ACCESSWIRE / August 1, 2024 / If you suffered a loss on your Humana Inc. (NYSE:HUM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
